Thorne HealthTech, Inc.
Thorne HealthTech, Inc. Fundamental Analysis
Thorne HealthTech, Inc. (THRN) shows weak financial fundamentals with a PE ratio of 34.30, profit margin of 6.85%, and ROE of 11.90%. The company generates $0.2B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 54.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze THRN's fundamental strength across five key dimensions:
Efficiency Score
WeakTHRN struggles to generate sufficient returns from assets.
Valuation Score
ModerateTHRN shows balanced valuation metrics.
Growth Score
ModerateTHRN shows steady but slowing expansion.
Financial Health Score
ExcellentTHRN maintains a strong and stable balance sheet.
Profitability Score
WeakTHRN struggles to sustain strong margins.
Key Financial Metrics
Is THRN Expensive or Cheap?
P/E Ratio
THRN trades at 34.30 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, THRN's PEG of 0.34 indicates potential undervaluation.
Price to Book
The market values Thorne HealthTech, Inc. at 3.71 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 42.67 times EBITDA. This signals the market has high growth expectations.
How Well Does THRN Make Money?
Net Profit Margin
For every $100 in sales, Thorne HealthTech, Inc. keeps $6.85 as profit after all expenses.
Operating Margin
Core operations generate 2.40 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.90 in profit for every $100 of shareholder equity.
ROA
Thorne HealthTech, Inc. generates $6.82 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Thorne HealthTech, Inc. generates limited operating cash flow of $5.35M, signaling weaker underlying cash strength.
Free Cash Flow
Thorne HealthTech, Inc. generates weak or negative free cash flow of $-12.95M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.24 in free cash annually.
FCF Yield
THRN converts -2.30% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
34.30
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.34
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.71
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.41
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.32
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.95
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.12
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.03
vs 25 benchmark
How THRN Stacks Against Its Sector Peers
| Metric | THRN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 34.30 | 23.25 | Worse (Expensive) |
| ROE | 11.90% | 1240.00% | Weak |
| Net Margin | 6.85% | -9728.00% (disorted) | Weak |
| Debt/Equity | 0.32 | 0.77 | Strong (Low Leverage) |
| Current Ratio | 2.95 | 2.54 | Strong Liquidity |
| ROA | 6.82% | -203388.00% (disorted) | Weak |
THRN outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Thorne HealthTech, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Dividend, Low Volatility
EPS CAGR
N/A
Industry Style: Defensive, Dividend, Low Volatility
FCF CAGR
N/A
Industry Style: Defensive, Dividend, Low Volatility